Use of Sacral Neuromodulation in the Management of ... - SUNA
Use of Sacral Neuromodulation in the Management of ... - SUNA Use of Sacral Neuromodulation in the Management of ... - SUNA
Learning Objectives: After completing this program you will be able to: • Discuss the prevalence of urinary urgency-frequency, urinary urge incontinence and/or urinary retention. • Define sacral nerve stimulation (SNS) • Discuss the treatment algorithm used to treat urinary urgencyfrequency, urge incontinence and retention. • Discuss the theory of mechanism of action of sacral nerve stimulation. • Explain the basic steps for the test stimulation and implant procedures used for InterStim Therapy • Identify the implantable and external equipment used for sacral nerve stimulation. • State the FDA approved indications for SNS. • Identify patients appropriate for SNS when provided a case scenarios.
Voiding Dysfunction: A Hidden Problem • Patients are embarrassed to talk to healthcare providers about voiding problems • Many providers typically do not ask patients about voiding problems • Quality of life issues can include: Anxiety, depression, infections, nocturia, odors, embarrassment, diet restrictions, discomfort / pain, limitations of social activities and employment opportunities, and cost of protective garments
- Page 1 and 2: Use of Sacral Neuromodulation in th
- Page 3: Program Goal To discuss the prevale
- Page 7 and 8: Filling Phase • Automatic Actions
- Page 9 and 10: Abnormal Micturition Voiding dysfun
- Page 11 and 12: Overview Sacral Nerve Stimulation (
- Page 13 and 14: SNS - Therapy SNS utilizes mild ele
- Page 15 and 16: Pharmacotherapy vs. SNS Therapy Pha
- Page 17 and 18: 5-Year Clinical Efficacy Urge Incon
- Page 19 and 20: 5-Year Clinical Efficacy Urinary Re
- Page 21 and 22: Treatment Algorithm For Urinary Urg
- Page 23 and 24: Other Issues Influencing Patient Se
- Page 25 and 26: Test & Implant Procedures • 1 st
- Page 27 and 28: Voiding Diary Documentation 3 days
- Page 29 and 30: 2 nd Stage Implant Procedure 2 nd S
- Page 31 and 32: Benefits of SNS Potential Adverse E
- Page 33 and 34: Case Studies Retention with frequen
- Page 35 and 36: Voiding Diary • Pt voids 2-4 oz q
- Page 37 and 38: Strains to Void
- Page 39 and 40: Urodynamic Results • Normal stora
- Page 41 and 42: Post InterStim Implant • Doing ex
- Page 43 and 44: Utilization of Multiple Modalities
- Page 45 and 46: Management of Care • Life choices
- Page 47 and 48: Summary • SNS is an effective tre
- Page 49 and 50: Revision for SUNA Oct 2010 - Lisa Z
Learn<strong>in</strong>g Objectives:<br />
After complet<strong>in</strong>g this program you will be able to:<br />
• Discuss <strong>the</strong> prevalence <strong>of</strong> ur<strong>in</strong>ary urgency-frequency, ur<strong>in</strong>ary<br />
urge <strong>in</strong>cont<strong>in</strong>ence and/or ur<strong>in</strong>ary retention.<br />
• Def<strong>in</strong>e sacral nerve stimulation (SNS)<br />
• Discuss <strong>the</strong> treatment algorithm used to treat ur<strong>in</strong>ary urgencyfrequency,<br />
urge <strong>in</strong>cont<strong>in</strong>ence and retention.<br />
• Discuss <strong>the</strong> <strong>the</strong>ory <strong>of</strong> mechanism <strong>of</strong> action <strong>of</strong> sacral nerve<br />
stimulation.<br />
• Expla<strong>in</strong> <strong>the</strong> basic steps for <strong>the</strong> test stimulation and implant<br />
procedures used for InterStim Therapy<br />
• Identify <strong>the</strong> implantable and external equipment used for<br />
sacral nerve stimulation.<br />
• State <strong>the</strong> FDA approved <strong>in</strong>dications for SNS.<br />
• Identify patients appropriate for SNS when provided a case<br />
scenarios.
Change language